Altre lingue Ovid Therapeutics Inc.

Azioni

OVID

US6904691010

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 23/04/2024			Variaz. 5gg	Var. 1 gen.
3,2 ^USD	+1,59%		+0,95%	-0,62%

08/03	Ovid Therapeutics Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
08/03	Ovid Therapeutics Inc. riporta i risultati degli utili per il quarto trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04/04
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus Post Grant Review	28/03
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Ovid Therapeutics : Corporate Presentation	08/03
Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562	08/03
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	08/03
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	08/03
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
Ovid Therapeutics Inc.(NasdaqGS:OVID) added to NASDAQ Biotechnology Index	18/12
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting	04/12
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	01/12
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	01/12
Ovid Therapeutics : Corporate Presentation	03/11
Ovid Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
Earnings Flash (OVID) OVID THERAPEUTICS Reports Q3 Revenue $108,972	03/11
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates	03/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ovid Therapeutics Inc.

Azioni

OVID

US6904691010

Altre lingue

Filtri